Avalyn Pharma Inc.

AVLN chart

Avalyn Pharma Inc. news

• Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Now Rated "Moderate Buy" by Sell-Side Brokerages

  MarketBeat · Oct 26, 6:38 AM EDT

• Avalyn Pharma (NASDAQ:AVLN) Stock Falls 5.9% - What's Next?

  MarketBeat · Oct 23, 1:26 PM EDT

• Syndax Pharmaceuticals Stock Plunges. A Failed Trial Deals Blow to Growth Plans.

  Yahoo Finance · Oct 13, 11:24 AM EDT

• Avalyn Pharma (AVLN) Following AP02 Phase 1 Data Is Its Valuation Too Pricey

  Yahoo Finance · Sep 23, 5:15 AM EDT

• Avalyn Publishes Phase 1 Data Highlighting AP02’s Lung-Targeted Delivery and Encouraging Safety Profile

  Yahoo Finance · Sep 21, 9:00 AM EDT

• Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors

  Yahoo Finance · Sep 16, 4:01 PM EDT

• Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

  Yahoo Finance · Sep 8, 8:00 AM EDT

• Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

  Yahoo Finance · Sep 8, 8:00 AM EDT

• Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026

  Yahoo Finance · Aug 24, 4:01 PM EDT

• Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights

  Yahoo Finance · Aug 12, 8:00 AM EDT

• What It Means To Hold Moderna Stock In A Crash

  trefis.com · Jul 13, 9:12 AM EDT

• Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis

  Yahoo Finance · Jun 17, 8:00 AM EDT

Avalyn Pharma Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-09-16
• 10-Q10-Q2026-08-12
• 8-K8-K2026-08-12
• 8-K8-K2026-07-01
• 8-K8-K2026-06-17
• 10-Q10-Q2026-06-03
• 8-K8-K2026-06-03
• 8-K8-K2026-05-01
• S-1S-12026-04-08

About Avalyn Pharma Inc.

Ticker

AVLN (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Boston, MA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1540171

Former names

Genoa Pharmaceuticals, Inc.

Frequently asked questions